Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Ertumaxomab> ?p ?o. }
Showing items 1 to 50 of
50
with 100 items per page.
- Ertumaxomab abstract "Ertumaxomab (trade name Rexomun) is a rat-murine hybrid monoclonal antibody designed to treat some types of cancer. Phase II clinical trial evaluating the treatment of breast cancer was terminated due to change in Fresenius' development plans.It is a so-called trifunctional antibody which works by linking T-lymphocytes and macrophages to the cancer cells.".
- Ertumaxomab atcPrefix "none".
- Ertumaxomab casNumber "509077-99-0".
- Ertumaxomab wikiPageID "9042799".
- Ertumaxomab wikiPageRevisionID "544658965".
- Ertumaxomab atcPrefix "none".
- Ertumaxomab casNumber "509077".
- Ertumaxomab chemspiderid "NA".
- Ertumaxomab hasPhotoCollection Ertumaxomab.
- Ertumaxomab mabType "3".
- Ertumaxomab source "axo".
- Ertumaxomab target CD3_(immunology).
- Ertumaxomab target neu.
- Ertumaxomab tradename "Rexomun".
- Ertumaxomab type "mab".
- Ertumaxomab verifiedfields "changed".
- Ertumaxomab verifiedrevid "457120720".
- Ertumaxomab subject Category:Monoclonal_antibodies_for_tumors.
- Ertumaxomab type Abstraction100002137.
- Ertumaxomab type Antibody115027189.
- Ertumaxomab type Chemical114806838.
- Ertumaxomab type Compound114818238.
- Ertumaxomab type Macromolecule114944888.
- Ertumaxomab type Material114580897.
- Ertumaxomab type Matter100020827.
- Ertumaxomab type Molecule114682133.
- Ertumaxomab type MonoclonalAntibodiesForTumors.
- Ertumaxomab type MonoclonalAntibody115029781.
- Ertumaxomab type OrganicCompound114727670.
- Ertumaxomab type Part113809207.
- Ertumaxomab type PhysicalEntity100001930.
- Ertumaxomab type Protein114728724.
- Ertumaxomab type Relation100031921.
- Ertumaxomab type Substance100019613.
- Ertumaxomab type Thing100002452.
- Ertumaxomab type Unit109465459.
- Ertumaxomab type Drug.
- Ertumaxomab type DrugProduct.
- Ertumaxomab type FunctionalSubstance.
- Ertumaxomab comment "Ertumaxomab (trade name Rexomun) is a rat-murine hybrid monoclonal antibody designed to treat some types of cancer. Phase II clinical trial evaluating the treatment of breast cancer was terminated due to change in Fresenius' development plans.It is a so-called trifunctional antibody which works by linking T-lymphocytes and macrophages to the cancer cells.".
- Ertumaxomab label "Ertumaxomab".
- Ertumaxomab label "Ertumaxomab".
- Ertumaxomab label "إرتوماكسوماب".
- Ertumaxomab sameAs Ertumaxomab.
- Ertumaxomab sameAs m.027vnc6.
- Ertumaxomab sameAs Q3732639.
- Ertumaxomab sameAs Q3732639.
- Ertumaxomab sameAs Ertumaxomab.
- Ertumaxomab wasDerivedFrom Ertumaxomab?oldid=544658965.
- Ertumaxomab isPrimaryTopicOf Ertumaxomab.